Thus, the addition of anti-CTLA-4 antibody during the initial TIL culture increases the proportion of CD8+ T cells in ovarian cancer TILs and leads to an increased amount of CD8+ T cells after the rapid expansion without additional anti-CTLA-4 antibody during the rapid expansion. This evidence concerns the gene CD8A and ovarian carcinoma.